News & Updates
Filter by Specialty:
No benefit to adding 5-ASAs to steroids in acute severe UC
The addition of 5-aminosalicylic acid (5-ASA) to standard corticosteroid treatment did not improve outcomes in patients hospitalized with acute severe ulcerative colitis (UC), according to a study presented at the Crohn’s and Colitis Congress 2022.
No benefit to adding 5-ASAs to steroids in acute severe UC
11 Feb 2022
Sleep problems plague IBD patients, require more attention
The opinion that inflammatory bowel disease (IBD) is associated with poor sleep is not uncommon among patients with IBD, according to a study. Moreover, these individuals tend to think and behave in manners that worsen sleep and their disease.
Sleep problems plague IBD patients, require more attention
11 Feb 2022
Obesity, diabetes, family history up prostate cancer risk in IBD patients
A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
IBD patients anxious over severe COVID-19 risk
Patients with inflammatory bowel disease (IBD) report that the COVID-19 pandemic is a “major concern” for them, reveals a study, noting that the cumulative prevalence is low in this cohort. At-risk patients must be identified and counseled individually.
IBD patients anxious over severe COVID-19 risk
10 Feb 2022
Pfizer/BioNTech shots effective in IBD patients
The Pfizer-BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19) effectively reduces the risk of serious outcomes and hospitalization in patients with inflammatory bowel diseases (IBD), though with slight variance in effectivity with respect to ongoing medications, reports a Qatar study presented at the recently concluded 2022 Crohn’s & Colitis Congress (CCC 2022).